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Most T  cells recognize antigen in association with either major histocompati- 
bility complex (MHC) ~ class I or II molecules. This has led to the hypothesis that 
the  specificity  of the  T  cell  receptor  is  for  self MHC  and  foreign  antigen. 
Recently, it has been shown that the expression of T  cell surface markers,  T4/ 
T8 in man (1-10) and L3T4/Lyt-2 in the mouse (11-19), is generally associated 
with the T  cells' MHC class restriction,  rather  than their functional subpopula- 
tions as previously thought. In general, T4 or L3T4 antibodies block the function 
of  class  II-restricted  T  cells  (1-9,  16-19)  whereas  T8  or  Lyt-2  antibodies 
functionally block class I-restricted T  cells (1, 2, 5, 7-9,  11-15). 
These T  cell surface markers may interact with nonpolymorphic determinants 
of the MHC molecule since these T  cell surface markers are not polymorphic, as 
opposed to  the  T  cell antigen  receptor,  which  is polymorphic  and  recognizes 
antigen  in association with a  polymorphic determinant  of the MHC. Perhaps a 
combination  of at  least  these  two  interactions  leads  to  a  cumulative  binding 
avidity  high  enough  to  trigger  T  cell  function.  This  hypothesis  was recently 
tested (19) by using a large panel of antigen (Ag) and I region (Ag/I)-restricted 
murine T  cell hybridomas. The ability of the panel of hybrids to respond to low 
concentrations  of antigen  was  correlated  with  insensitivity  to  anti-Ia  or  anti- 
L3T4 blocking. These results suggest that a T  cell with an Ag/I receptor with a 
high avidity for Ag/I does not require an  L3T4/I interaction  and, conversely, 
that  T  cells  with  low  avidity  for  Ag/I  require  the  L3T4/I  interaction  for 
triggering.  This implies that L3T4 may be important in cell-cell interaction but 
not for antigen/MHC-restricted recognition. 
A  novel  T  cell  hybridoma  (20)  with  antigen  specificity for  a  class  I  MHC 
antigen allowed us to test directly the role of L3T4. The hybridoma, 3DT52.5, 
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TABLE  I 
Monoclonal Antibodies Used in These Experiments 
Monoclonal  antibody  Target molecules  Source  Reference 
GK 1.5  L3T4  SN  16 
KJ12-98.5  Ag receptor on T cell  Ascites  26 
hybridoma 3DT52.5 
M12-4  Lyt-1  SN  27 
53.7  Lyt-2  SN  28 
M5/114  I-A  d'b, I-E  d'k  SN  29 
10.2.16  I-A  k'*'f'r'u  SN  30 
T24/31.7  Thy-1  SN  31 
28.14.8  La(C2)  SN  32 
30.5.7  Ld(N,C1)  SN  32 
34.2.12  Dd(c2)  SN  33 
34.5.8  Da(N,C1)  SN  33 
expresses L3T4 and recognizes a  D  region gene product of the H-2  d haplotype 
(19).  The exact nature  of the antigen recognition was  unclear since  3DT52.5 
did not respond to all D d stimulators used. 
In this paper, we have examined the fine specificit), of recognition by 3DT52.5. 
Using L cells transfected (21-24) with either the D°gene or recombinant genes, 
where  the  exons  encoding  the  N  and  C1  domains  of D d  and  L d  have  been 
exchanged, as stimulators we found that 3DT52.5 recognizes the N/C1  domain 
of D d. Moreover, 3DT52.5, which produces interleukin 2 (IL-2) after activation, 
was  found to lyse D d target cells.  We  have  used  both functions of this T  cell 
hybridoma to investigate the role of L3T4 in recognition of D d using Ia  ÷ and 
Ia- cells to present D d. 
Materials and Methods 
Mice.  C57BL/6, BALB/cBy, A/J, AKR, and (BALB/c x  DBA/2)FI mice were pur- 
chased from The Jackson Laboratory, Bar Harbor, ME. B10A.5R/SgSn mice were bred 
in our animal facility from breeding pairs originally from The Jackson Laboratory. 
d  b  k  Cell Lines.  P815 (H-2), MBL2 (H-2), and RDM4 (H-2) were maintained by weekly 
passage  in  ascites  of (BALB/c  x  DBA/2)FI,  C57BL/6,  and  AKR  mice  respectively. 
A20.2J.AG (A20)(H-2  d, Ia  +) was maintained in vitro. 
L cells (Lmtk-, DAP-3) (21) were cultured in RPMI 1640 supplemented with 10% fetal 
bovine serum, glutamine, and antibiotics in a humidified 5% CO~/95% air environment. 
Cloned L cells that were transfected with H-2L  a (T1.1.1), H-2D  d (T4.8.3) genes (21, 23) 
and with recombinant genes in which the exons encoding the N and C1  domains of H- 
2D  d and H-2L  d had been exchanged (22, 24), indicated as H-2Ld/D  d (T37.1.3) and H- 
2 Dd/L  d (T  37.2.1) (see Results), were maintained in hypoxanthine, aminopterin, thymidine 
(HAT)-supplemented media. Cells were detached by versene (Gibco Laboratories, Grand 
Island, NY) treatment. 
Monodonal  Antibodies.  Monoclonal  antibodies  were  prepared,  either  as  a  cell-free 
supernatant of hybridoma cultures or as an ascitic fluid from irradiated mice carrying the 
hybridoma as a tumor. A list of monoclonal antibodies and their sources used in these 
experiments is shown  in  Table I.  The concentration of the various antibodies varied 
according to experimental protocols, as indicated in  Results.  Antibodies were used at 
saturating concentrations. 
T  Cell  Hybridomas.  The  T  cell  hybridomas  used  in  these  experiments  have  been GREENSTEIN ETAL.  1215 
previously described (20,  34).  Briefly, 3DT52.5 resulted from a  fusion of (T,G)-A-L- 
primed T  cell blasts with an azaguanine resistant subline of the AKR thymoma BW5147. 
3DT52.5 was  characterized as a  hybridoma that secretes IL-2 in response to a  class  I 
antigen coded for the  H-2D  d region, although the molecular nature of the antigen is 
unknown.  A  variant of 3DT52.5  was prepared by passaging the cloned hybridoma in 
tissue culture and recloning the hybrids at limiting dilution. 3DT52.5.8 was characterized 
as an IL-2-producing hybridoma with the same antigen specificity as the parent, but which 
did not express the L3T4 marker. 
Culture Conditions.  All cell lines were grown and tested in RPMI  1640 supplemented 
with 10% fetal bovine serum, 2 mM L-glutamine, 5 X 10  -5 M 2-mercaptoethanol, penicillin 
(100 #g/ml), and streptomycin (100/zg/ml).  For stimulation of IL-2 secretion, 1 X  105 
hybridoma cells were co-cultured with various numbers of spleen cells or tumor cells 
(previously exposed to 10,000 tad gamma irradiation and chosen to result in suboptimal 
stimulation so that blocking could be detected) in a total volume of 1 ml. After 20-24 h, 
supernatants (SN) were removed and assayed for the presence of IL-2. 
IL-2 Assay.  SN were titrated by serial twofold dilutions and assayed for IL-2 by their 
ability to support the proliferation of the IL-2-dependent T  cell line, HT-2 (35).  Prolif- 
eration was assessed by the incorporation of [aH]thymidine during a 4-h pulse with 1 #Ci 
[SH]thymidine/well. Data are presented as U/ml relative to the [SH]thymidine incorpo- 
ration of HT-2  from a  standard  rat  concanavalin A  (Con  A)  SN.  The  half-maximal 
incorporation from the Con A SN titration was defined as 100 U/ml ILo2. The standard 
error is derived from the mean of the cpm from the HT2 assay. Each table represents a 
series of at least three experiments. 
Cytotoxic T Lymphocyte  Assay.  Target cells were prepared by harvesting tumor cells and 
incubating -5 x  108 cells with 150 #Ci Na~ 51CrO4 (New England Nuclear, Boston, MA) 
for 1 h at 37°C in Eagle's minimum essential media supplemented with 10% fetal bovine 
serum, penicillin, and streptomycin, 1% nonessential amino acids, and 2 mM L-glutamine 
(SMEM). Labeled cells were washed three times and 5 x  10  s cells were mixed with various 
numbers of hybridoma cells in 150 #1 of SMEM in V-bottomed microtiter plates (Linbro 
Chemical Co., Hamden, CT). Plates were spun (100g, 5 min) and incubated for 6 h at 
37°C. Plates were spun again and  100 #l of SN harvested to determine the amount of 
radioactivit,  y released. Specific lysis was calculated as follows'.  100  x  -[(5*Cr51released  by 
hybndomas +  target cells) -  (5~Cr released by target cells alone)/(maxlmal  Cr released 
with 1.5%  Triton X-100) -  (5~Cr released by target cells alone)]. Standard deviation of 
replicates was  <5%.  The  experiments presented  are  representative of at  least  three 
experiments. 
Enzymedinked  Immunosorbent  Assay (ELISA).  Binding of antibodies to T cell hybridomas 
was assessed  with an ELISA, as previously described (20). 5 x  105 hybridoma cells were 
incubated in media with a test antibody in 96-well culture dishes that were precoated with 
fetal calf serum  (FCS).  After a  1-h  incubation at  0°C,  the  plates  were  washed  with 
phosphate-buffered saline-2% FCS. This was followed by a  1-h incubation with 100 #1 of 
a  1:250  dilution  of alkaline  phosphate-coupled rabbit  anti-mouse  Ig  antibody.  After 
thorough  washing,  175  #1  of substrate,  para-nitrophenyl phosphate  as  a  1.67  mg/mi 
solution in 0.1  M glycine buffer, pH 10.4 with 1 mM MgCI2 and 1 mM ZnCI,, was added. 
The plates were incubated for 1 h at 37°C, then read for optical density (OD) with an 
ELISA reader using a 405 nm filter. The results are presented in arbitrary units of OD 
after subtraction of the background OD of wells lacking the test antibody. 
Results 
Mapping of the Fine Specifidty  of 3DT52.5.  Previous work  (20)  to determine 
the specificity of 3DT52.5 showed that this T  cell hybridoma was specific for a 
gene product of the D  region of the MHC.  Not all H-2  d haplotype, Dd-bearing 
cells were effective stimulators; therefore, the exact specificity of 3DT52.5 was 
unknown.  To test directly whether  3DT52.5  is specific for D d or another H-2 
antigen  that  is  not  serologically defined but  genetically linked  to  D d,  L  cells 1216  ROLE OF L3T4 IN RECOGNITION OF Ia 
Exp. 1 
TABLE  II 
3DT52.5 Responds to the N/C1 Domain olD d 
3DT52.5 stimulated with:  IL-2 production 
U/ml 
BALB/c spleen (H-2  d)  330 +  13 
P815 (H-2  d)  478 + 8 
MBL2 (H-2  b)  9 +  1 
DAP (H-2  k)  <5 
TI.I.1 (L  d)  <5 
T4.8.3 (D  d)  178 + 20 
Exp. 2  T37.1.3 (Ld/D  d)  16 +  2 
T37.2.1 (Dd/L  d)  280 :t: 13 
105 3DT52.5 were cultured for 20 h with 5 X 105 BALB/c spleen cells, 
105 tumor cells, or 105 L cells, as described in Materials and Methods. 
transfected  with  the  D d  or  L d  genes  were  used as stimulators.  The  results  of 
these experiments are shown in Table II. 3DT52.5 responded by producing IL- 
2 when stimulated with BALB/c splenocytes, P815, or L  cells transfected with 
the D d gene but not with L cells transfected with the L d gene. This demonstrates 
that 3DT52.5 is specific for the D d gene product. 
L cells that have been transfected with recombinant genes made by exchanging 
exons encoding various domains of L d and D d (22, 24) were used to determine 
the fine specificity of 3DT52.5. T37.1.3 is an L cell transfected with a recombi- 
nant  gene  and  expresses a  hybrid  H-2  molecule  composed of the  N  and  C1 
domains of L d and the C2 domain of Dd; T37.2.1  is an L cell transfected with a 
recombinant gene composed of the exons encoding the N and C 1 domains of D d 
and the  C2 domain  of L d.  As shown in Table  II, experiment  2,  only T37.2.1 
stimulated IL-2 production by 3DT52.5, demonstrating that 3DT52.5 is specific 
for the N and/or C 1 (N/C 1) domains of the D O  molecule. 
These results are confirmed by studies in which monoclonal antibodies were 
used to block stimulation  of 3DT52.5  by the  Dd-transfected  L  cell  (shown  in 
Table  III).  These  experiments  demonstrated  that  3DT52.5  stimulation  was 
blocked by antibody directed at the N/C 1 domain of D d and by a clone-specific 
anti-3DT52.5  O d receptor antibody (KJ12-98.15)  (25).  Interestingly,  antibody 
directed at the C2 domain of D O appears to enhance IL-2 production by 3DT52.5. 
Collectively, these experiments  map the recognition  of 3DT52.5  to the  N/C1 
domain of the D O  gene product. 
Lyric Activity of 3DT52.5.  The unusual nature of the recognition of 3DT52.5, 
in that it directly recognizes a "self" class I molecule, led us to postulate that IL- 
2 production may not be its only function. The traditional association ofcytotoxic 
T  cell function with MHC class I recognition led us to assess whether 3DT52.5 
also had cytolytic activity. 3DT52.5 was tested for cytotoxicity against a panel of 
targets, as shown in Fig.  1.3DT52.5 lysed A20 and P815, both of which express 
O d,  but  did  not  lyse  RDM4,  which  expresses  H-2  k.  Therefore,  3DT52.5  has 
cytolytic activity with specificity for H-2 d.  However, 3DT52.5 had no cytolytic 
activity against BALB/c blasts, YAC-1, or the transfected L cells (data not shown). 
Inability to lyse these targets may reflect quantitative  differences in expression GREENSTEIN ET AL. 
TABLE  III 
3DT52.5 Is Inhibited by Antibody to the Idiotype of the T Cell Receptor 
and to the N/C1 Domain of D d 
Antibody added directed  IL-2 production  against:* 
3DT52.5 stimulated 
with T4.8.3 
U/ml 
872 _+ 7 
3DT52.5 D d receptor  219 _+ 7 
Lyt-2  725 +  3 
Dd(N,C1)  330 _+ 6 
Dd(C2)  2,728 _+ 81 
Ld(N,C1)  1,248 _  83 
Ld(C2)  786 _  40 
3DT52.5 stimulated as in Table II, except at 106 cells/ml. 
* Antibodies used as listed in Table I; final concentration of monoclonal 
Ab as SN was 20% and as ascites, 5%. 
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FIGURE  1.  Cytolytic activity of 3DT52.5.3DT52.5  killing of P815 (m),A20 (O), and RDM4 
(0). Spontaneous release was 10-25% of total counts in a 6-h assay. 
of  D  d,  differences  in  posttranscriptional  modification  of  D  d,  or  differential 
expression of invarient target antigens. Perhaps the cytolytic event requires a 
higher avidity interaction with D  d than the interaction leading to IL-2 production. 
Target  and  Effector Surface Antigens  Important  in  3DT52.5  Recognition.  Re- 
cognition of the D  d molecule by 3DT52.5 resulted in both IL-2 production and 
cytolytic  activity.  The  direct  recognition  of a  class  I  molecule by  an  Lyt- 
l+2-,L3T4 + T  cell hybridoma (Table IV) affords the opportunity to study the 
functional recognition of Ia by L3T4. We compared the ability of anti-Ia and 
anti-L3T4 to block lytic activity (Fig. 2) and IL-2 production (Tables V and VI). 
The results, shown in Fig. 2, demonstrate that the cytolytic activity of 3DT52.5 
was blocked by the addition of saturating concentrations of anti-Ia  d and by anti- 
L3T4 only when the target cell expressed Ia (shown by the A20 target, Fig. 2B). 
In contrast, the lysis of the Ia- target, P815 (Fig. 2A), was unaffected by anti-Ia 
and anti-L3T4; the slight inhibition by anti-L3T4 was only seen in one experi- 1218  ROLE OF L3T4 1N RECOGNITION OF Ia 
TABLE  IV 
Expression of T Cell Surface Markers by T Cell Hybridomas 
Antibodies directed against: 
OD 4, SE (×10  s) on T  cell 
hybridomas* 
3DT52.5  3DT52.5.8 
Thy-1  581 ±  30  620 +  27 
L3T4  164 3= 15  2 +  3 
Lyt-2  l 0 ±  8  2 4. 8 
D d receptor on 3DT52.5  353 4. 26  813 4- 35 
* As described in Materials and Methods. 
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FIGURE 2.  3DT52.5 cytolytic T  lymphocyte activity is blocked by anti-L3T4 and anti-Ia only 
when  the  target  expresses  Ia.  Lytic  activity  of  3DT52.5  against  P815  (A)  and  A20  (B). 
Antibodies used (as listed in Table I) were: no antibody (x); anti-IA  d IE  d (AI; anti-IA  k (A); anti- 
D d N/C1 ([-1); anti-L3T4 (@); anti-D  d receptor on 3DT52.5 (O). The anti-D  receptor antibody 
containing ascites was diluted 10-fold more than other antibodies used. Effector/target ratio 
was 10:1. The SE of the percent specific lysis was <3%. 
TABLE  V 
Stimulation of 3DT52.5 Requires the L3T4 Receptor When the 
Stimulator Is Ia  ÷ 
IL-2 production* 
Antibody added to culture directed  3DT52.5 stimulated with: 
against:* 
T4.8.3  A20 
100  100 
D d receptor on 3DT52.5  <5  9 
L3T4  104  29 
Lyt-I  I00  98 
* Antibody added to cultures were 20% for SN and 5% for ascites. 
* 105 3DT52.5 were cultured for 20 h  with 5 X  10  * T4.8.3 or A20 cells 
as stimulators. The amount of IL-2 production was determined by HT- 
2 assay, and is presented as the percent of IL-2 production in the absence 
of added antibody. Amount of IL-2 produced: 480 U/ml with T4.8.3 
and 580 U/ml with A20. The SE from the HT-2 assay was <10% of the 
total cpm. GREENSTEIN ET AL.  1219 
TABLE  VI 
L3T4 Receptor Recognizes a Nonpolymorphic Determinant of la 
IL-2 production** 
3DT52.5  stimulated with: 
Exp. 1  Exp. 2  Exp. 3 
Antibody added 
directed against:  T4.8.3  A20  B10.A(5R)  A/Jk 
D d  Ddla  d  DdlAblE  k  D  Ia 
--  100  100  100  100 
I-Ad'b,l-E  a'k  106  49  57  91 
I-A  k  100  119  100  31 
DO(N/C1)  10  22  27  14 
L3T4  ND  0  ND  33  8 
* 105 3DT52.5 were stimulated for 20 h with 5 x  104 T4.8.3 or A20 or 
5 × 10  ~ A/J splenocytes. IL-2 production was calculated as in Table V. 
Amount of IL-2 produced: 50 U/ml with T4.8.3, 148 U/ml with A20, 
192 U/ml with A/J spleen, and 120 U/ml with B10.A(SR). 
* See Table IV. 
! Not done. 
ment. The lytic activity of 3DT52.5 was completely blocked by anti-D  ° and anti- 
D d receptor on  3DT52.5  on both the  Ia  + and Ia- targets.  Comparable  results 
were seen when IL-2 production was assayed (Table V and Table VI, experiment 
1). These experiments suggest that while 3DT52.5 has specific receptors for the 
D d molecule, recognition of Ia determinants via the L3T4 molecule may influ- 
ence the antigen-dependent triggering of 3DT52.5 T  cell function. 
To determine whether  L3T4  reacts with a  polymorphic determinant of Ia, 
the  effect  of anti-Ia  on  the  stimulation  of  3DT52.5  with  A/J  (Dd,Ia  k)  and 
B10.A(5R)(Da,IAb,IE k) splenocytes was studied. The results, shown in Table VI, 
demonstrate that anti-L3T4 and the appropriate anti-Ia blocked the interaction 
of 3DT52.5. The correlation ofanti-L3T4 and anti-Ia blocking is highly specific, 
as  shown  below.  This  suggests  that  L3T4  interacts  with  a  nonpolymorphic 
determinant of Ia. Although 3DT52.5  has specificity for the D a antigen alone, 
the  presence  of  Ia  on  the  stimulator  cell  links  the  triggering  event  of  D a 
recognition to the L3T4/Ia interaction. 
Function  of an L3T4-  Variant  of 3DT52.5.  3DT52.5.8  is a  L3T4- variant of 
3DT52.5 (Table IV). 3DT52.5.8 produced IL-2 in response to T4.8.3 and A20 
(Table VII) but,  in contrast to 3DT52.5,  3DT52.5.8  was not blocked by anti- 
L3T4 or anti-Ia reagents. This demonstrates that anti-Ia blocking can be corre- 
lated with the expression of L3T4 when the T  cell receptor for antigen is not 
restricted by Ia.  These  results also show that the clonotypic 3DT52.5  antigen 
receptor is not restricted by Ia and that triggering of 3DT52.5  is not strictly 
related to an L3T4/Ia interaction. We cannot exclude the remote possibility that 
another cell surface structure is coordinately expressed with L3T4, blocked by 
steric hindrance, and also not expressed by 3DT52.5.8. 
Surprisingly,  3DT52.5.8  did  not  demonstrate  any  lytic  capacity  (data  not 
shown).  However,  this does  not necessarily imply a  requirement  for  L3T4  in 
cytolysis, since 3DT52.5.8, a spontaneous variant, may possibly have lost expres- 
sion of other important functional molecules. 1220  ROLE OF L3T4 IN RECOGNITION OF Ia 
TABLE  VII 
An L3T4- Variant  of 3DT52.5 Is Not Inhibited by Anti-Ia 
IL-2 production* 
Antibody added directed  3DT52.5.8 stimulated with:  to:* 
T4.8.3  A20 
--  100  100 
Da(N/C1)  36  31 
IAd, IE  d  100  91 
IA  k  120  79 
L3T4  120  91 
* As in Table V. Amount of IL-2 produced: 483  U/ml with T4.8.2 and 
263 U/ml with A20. In the same experiment, 3DT52.5 stimulation with 
A20 was blocked by anti-Ia  a and anti-L3T4. 
Discussion 
Recently, there has been an accumulation  of evidence suggesting that  L3T4 
is  the  murine  homologue of the  human  T  cell  marker  Leu3/T4  (16-20) and 
that these human and mouse T  cell antigens are involved in the recognition of 
class II molecules (1-8,  16-10). Similar evidence leads to the association of Lyt- 
2 and  Leu-2/T8 with the recognition of class I antigens (1,  2,  5,  7-9,  11-15). 
The interaction  of T  cell surface markers and  MHC antigens may be involved 
in adding  to the  cumulative avidity needed  to trigger  T  cell function (20).  A 
direct test of this hypothesis has not been possible since it has been difficult to 
separate the binding of the T  cell antigen  receptor to an Ag/Ia complex from 
the L3T4 interaction with Ia. 3DT52.5 is a novel T  cell hybridoma in that it has 
an  antigen  receptor specific for a  self class I  antigen,  is  Lyt-2-, and  expresses 
L3T4 (20, 21).  3DT52.5 was shown to be antigen specific for the D d molecule 
by its ability to produce IL-2 when stimulated with L cells transfected with the 
D d gene. The fine specificity of its receptor is for the N/C1  domain of the D d 
molecule,  as  shown  by stimulation  with  L  cells  transfected  with  recombinant 
genes, in which the N/C 1 domains of D d and L d were exchanged, as well as by 
antibody blocking of IL-2 production. 
The experiments presented  in  this paper allowed the separate  evaluation of 
the T  cell receptor recognition of antigen and the role of L3T4. The recognition 
of D d by an  Lyt-2-,  L3T4 + T  cell hybridoma gave us the ability to separately 
evaluate  the  interaction  of L3T4  with  class  II  antigens.  We have  shown  that 
3DT52.5  is  inhibited  by anti-L3T4  and  anti-Ia  only when  the  stimulator  cell 
expressing  D d is  also  Ia +.  Although  anti-L3T4  is  bound  to  3DT52.5  in  both 
cases, the functional inhibition  by anti-L3T4 occurs only when the stimulator is 
Ia +. The anti-antigen  receptor on  3DT52.5  and anti-D d (N/C1  domains) com- 
pletely inhibits the reactivity of 3DT52.5  to both Ia  + and Ia- cells. The ability 
to block T  cell effector function of 3DT52.5  with anti-L3T4  implies that  the 
L3T4/I interaction  is involved in triggering by Ia  ÷ splenocytes or A20 but not 
with P815 or T4.8.3.  The blocking by anti-L3T4 and anti-Ia on Ia + stimulator 
or target cells was always less than total blocking. This may imply that while the 
Dd/D  d receptor on 3DT52.5  interaction  is essential for triggering  effector cell 
function,  the  L3T4/I  interaction  may  serve an  accessory function.  Since  the GREENSTEIN ET AL.  1221 
avidity of the recognition of D d on these different cell types by the  3DT52.5 
antigen receptor can not be quantitated,  we can only suggest that the L3T4/I 
interaction may be responsible for increasing the interaction avidity with the Ia  + 
cells to the triggering threshold. This may reflect the relative amount of expres- 
sion of D d on the target cells used, since T4.8.3 and P815 have more D d than 
A20 (data not shown). Since A20 has less D d, the L3T4/I interaction may raise 
the  cumulative  binding  avidity  to  the  triggering  threshold.  3DT52.5.8  may 
bypass this requirement when stimulated with A20 by the increased expression 
of the D d receptor (Table IV). 
The  experiments  presented  demonstrate  that  while  3DT52.5  has  antigen 
specificity  for  D d,  recognition  of  Ia  by  the  L3T4  molecule  can  affect  the 
triggering of effector T  cell function. When the avidity of the T  cell antigen 
receptor for antigen is less than the triggering threshold, the L3T4/I interaction 
may raise the cumulative binding avidity to the threshold. If the avidity of the T 
cell receptor for its antigen is high, there may be no additional requirement for 
other interaction  molecules. Thus, one can postulate an ordered requirement 
for cell-cell  interaction,  starting  with the T  cell antigen  receptor,  adding the 
L3T4/I or Lyt-2/class I interactions and other interaction antigens such as LFA- 
1, LFA-2, and LFA-3 (36) (LFA-2 and LFA-3 have as yet only been defined in 
human T  cell interactions),  all  leading to effective T  cell triggering.  Another 
possible explanation for the inhibition seen with anti-L3T4 and anti-Ia may be 
that the interaction of Ia, L3T4, and anti-L3T4 decreases the membrane mobility 
of 3DT52.5 or the Da-presenting cell, thus interfering with a necessary activation 
signal. This type of effect has been suggested by the decrease in B cell membrane 
mobility after Con A binding to surface immunoglobulin (37). 
L3T4 interacts with Ia, as shown by the ability of anti-L3T4 to block stimula- 
tion of 3DT52.5 by A/J and B10.A(5R) splenocytes and A20 tumor cells. These 
results demonstrate that the  L3T4  receptor on 3DT52.5  can interact with Ia 
from three distinct haplotypes. Therefore, the L3T4 surface marker on 3DT52.5 
may recognize a  nonpolymorphic determinant of Ia  shared  by  these  distinct 
haplotypes. Preliminary results (not shown) suggest that L3T4 interacts with I- 
A and I-E. 
The ability of anti-L3T4 to block class II-associated functions of cloned T  cells 
(16-18),  T  cell  hybridomas  (16,  18,  20),  and  bulk  T  cell  cultures  (17,  19) 
implicates L3T4 in the recognition of class II antigens. Similar conclusions have 
been drawn from experiments with Leu3 and T4 in human studies (1-9)  and 
regarding class I recognition by Lyt-2 and Leu-2/T8 (1, 2, 5, 7-9,  11-15). The 
L3T4 interaction with Ia has been shown to contribute to antigen recognition 
by Ag/I-specific  T  cell hybridomas at the level of recognition and binding to 
antigen-presenting cells (18) and in cytolytic T  cell clones before the lethal hit 
(16,  17). The data presented in this paper directly demonstrate the recognition 
of Ia  by  L3T4  in  the  absence  of an  I  region-restricted  antigen  interaction. 
Additionally, we have shown that L3T4 interacts with a nonpolymorphic deter- 
minant of Ia. In this manner, the L3T4 molecule may serve an accessory function 
to the T  cell antigen receptor. Binding to the antigen-presenting cell occurs via 
both receptors. A high avidity T  cell antigen receptor interaction can trigger the 1222  ROLE OF L3T4 IN RECOGNITION OF Ia 
cell to respond;  in contrast,  a  low avidity T  cell receptor may also require the 
L3T4/Ia interaction to gain the threshold-triggering avidity. 
The  physiological  role  of nonpolymorphic  L3T4-mediated  interactions  be- 
tween T  cells and antigen-presenting cells remains unclear. Interaction of L3T4 
with  Ia may allow T  cells to home to and  screen potential  antigen-presenting 
cells. Alternatively, the L3T4]I interaction may be involved in cell-cell commu- 
nication. 
Summary 
The expression of T4/T8  surface markers on human  T  cells and of L3T4/ 
Lyt-2 on murine T  cells has lead to the association of these surface markers with 
recognition of either class II or class I major histocompatibility complex (MHC) 
antigens.  It has been suggested that these T  cell surface antigens interact with 
MHC antigens. We have examined the role of L3T4 in the recognition of D d by 
the T  cell hybridoma, 3DT52.5. This T  cell hybridoma was found to be specific 
for the N/C 1 domain of D d. The recognition of a  class I antigen by an Lyt-2-, 
L3T4  ÷ T  cell hybridoma allowed the separate evaluation of interactions between 
L3T4/Ia and  the T  cell antigen  receptor,  D d.  Recognition by this hybridoma 
resulted in the production of interleukin 2 (IL-2) and cytolytic activity. Antibody 
blocking experiments have demonstrated that L3T4 was involved in triggering 
the effector function of 3DT52.5 only on Ia  + stimulator or target cells. We have 
demonstrated that an L3T4 ÷, D°-specific T  cell hybridoma,  3DT52.5,  uses the 
L3T4 molecule to directly interact with nonpolymorphic Ia determinants. 
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